General
Release from Glaxo Smith Kline (BIOC.CA) Regarding a Memorandum of Understanding
Published at 5 August 2026 at 13:08Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company regarding the memorandum of understanding with the Egyptian Drug Authority.
Release from the Company (421 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Release from the company regarding the memorandum of understanding with the Egyptian Drug Authority.
Release from the Company (421 KB)